Adebrelimab (Anti-B7-H1 / PD-L1 / CD274)

Synonyms: SHR-1316

Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1, cluster of differentiation 274, CD274) with promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC). MW: 145.8 kD.

Adebrelimab (Anti-B7-H1 / PD-L1 / CD274)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1, cluster of differentiation 274, CD274) with promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC). MW: 145.8 kD.

Product Details

CAS No. 2247114-85-6
Molecular Weight 145.8
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) | Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) supplier | purchase Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) | Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) cost | Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) manufacturer | order Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) | Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) distributor